Heleen Hanssens

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Multiple Myeloma

Drug Administration

Top Venues

International journal of molecular sciences

Medicinal research reviews

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Heleen Hanssens, Fien Meeus, Emma L Gesquiere, Janik Puttemans, Yannick De De Vlaeminck, Kim De Veirman, Karine Breckpot, Nick Devoogdt
Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties. International journal of molecular sciences 25 (11) (2024)
Heleen Hanssens, Fien Meeus, Emma L Gesquiere, Janik Puttemans, Yannick De De Vlaeminck, Kim De Veirman, Karine Breckpot, Nick Devoogdt
Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties. International journal of molecular sciences 25 (11) (2024)
Heleen Hanssens, Fien Meeus, Emma L Gesquiere, Janik Puttemans, Yannick De De Vlaeminck, Kim De Veirman, Karine Breckpot, Nick Devoogdt
Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties. International journal of molecular sciences 25 (11) (2024)
Heleen Hanssens, Fien Meeus, Kim De Veirman, Karine Breckpot, Nick Devoogdt
The antigen-binding moiety in the driver's seat of CARs. Medicinal research reviews 42 (1) (2021)
Janik Puttemans, Benoit Stijlemans, Marleen Keyaerts, Sam Vander Meeren, Wim Renmans, Karel Fostier, Pieterjan Debie, Heleen Hanssens, Magdalena Rodak, Marek Pruszynski, Kim De Veirman, Karin Vanderkerken, Tony Lahoutte, Alfred Morgenstern, Frank Bruchertseifer, Nick Devoogdt, Matthias D'Huyvetter
The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy. Molecular cancer therapeutics (2021)
Janik Puttemans, Yana Dekempeneer, Jos L Eersels, Heleen Hanssens, Pieterjan Debie, Marleen Keyaerts, Albert D Windhorst, Frank van der Aa, Quentin Lecocq, Karine Breckpot, Alfred Morgenstern, Frank Bruchertseifer, Tony Lahoutte, Nick Devoogdt, Matthias D'Huyvetter
Preclinical Targeted α- and β--Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies. Cancers 12 (4) (2020)